Natural History Study of MNGIE

NCT04245917 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-07-22

No results posted yet for this study

Summary

Non-interventional, prospective, multicenter, natural history study of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Conditions

  • Mitochondrial Neurogastrointestinal Encephalomyopathy

Interventions

OTHER

Non-interventional

Non-interventional natural history study

Sponsors & Collaborators

  • Entrada Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Michio Hirano, MD · Columbia University

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-06
Primary Completion
2025-02-28
Completion
2026-02-28

Countries

  • United States
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04245917 on ClinicalTrials.gov